proteomics.cancer.gov

Home - Office of Cancer Clinical Proteomics Research - National Cancer Institute

The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. Pharmacodynamic Proteomic Assay Panel for Monitoring Phospho-Signaling Networks. CPTAC researchers demonstrate utility of a pharmacodynamic multiplex immuno-MRM assay to study phosphorylated cell signaling networks. For more information, click here. CPTAC Proteomics Data Now on UCSC Genome Browser. For more information click here. Investigating RAS Signaling in Cancer.

http://proteomics.cancer.gov/

OVERVIEW OF proteomics.cancer.gov

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

22

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR PROTEOMICS.CANCER.GOV

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

February

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Monday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 3.9 out of 5 with 8 reviews

5 star

1

4 star

5

3 star

2

2 star

0

1 star

0

Hey there! Start your review of proteomics.cancer.gov

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

0.5 seconds

CONTACTS AT PROTEOMICS.CANCER.GOV

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

PAGES IN
THIS WEBSITE

22

SSL

EXTERNAL LINKS

52

SITE IP

129.43.254.36

LOAD TIME

0.516 sec

SCORE

6.2

PAGE TITLE

Home - Office of Cancer Clinical Proteomics Research - National Cancer Institute | proteomics.cancer.gov Reviews

<META> DESCRIPTION

The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. Pharmacodynamic Proteomic Assay Panel for Monitoring Phospho-Signaling Networks. CPTAC researchers demonstrate utility of a pharmacodynamic multiplex immuno-MRM assay to study phosphorylated cell signaling networks. For more information, click here. CPTAC Proteomics Data Now on UCSC Genome Browser. For more information click here. Investigating RAS Signaling in Cancer.

<META> KEYWORDS

1 skip to content

2 wwwcancer gov

3 intranet

4 what is proteomics

5 video tutorial

6 programs

7 cptac

8 sbir

9 trans nih programs

10 completed programs

CONTENT

Page content here

KEYWORDS ON PAGE

skip to content,wwwcancer gov,intranet,what is proteomics,video tutorial,programs,cptac,sbir,trans nih programs,completed programs,news and events,news and announcements,events,eprotein,resources,mouse biorepository,open data policy,protocols,about occpr

SERVER

Microsoft-IIS/7.5

POWERED BY

ASP.NET

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Home - Office of Cancer Clinical Proteomics Research - National Cancer Institute | proteomics.cancer.gov Reviews

https://proteomics.cancer.gov

The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. Pharmacodynamic Proteomic Assay Panel for Monitoring Phospho-Signaling Networks. CPTAC researchers demonstrate utility of a pharmacodynamic multiplex immuno-MRM assay to study phosphorylated cell signaling networks. For more information, click here. CPTAC Proteomics Data Now on UCSC Genome Browser. For more information click here. Investigating RAS Signaling in Cancer.

INTERNAL PAGES

proteomics.cancer.gov

1

News and Events - Office of Cancer Clinical Proteomics Research - National Cancer Institute

http://proteomics.cancer.gov/newsevents

The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. August 29, 2016. University of Victoria Genome British Columbia Proteomics Centre Partners with CPTAC. July 19, 2016. New Memorandum of Understanding in Clinical Proteogenomics Between the United States and Australia. July 11, 2016. Applied Proteogenomics OrganizationaL Learning and Outcomes (APOLLO) Network. June 29, 2016. May 25, 2016. December 28, 2015.

2

Completed Programs - Office of Cancer Clinical Proteomics Research - National Cancer Institute

http://proteomics.cancer.gov/programs/completed

The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. Clinical Proteomic Technologies for Cancer initiative. Mouse Proteomic Technologies Initiative. US Department of Health and Human Services. 160; National Institutes of Health. 160; National Cancer Institute. 160; USA.gov. NIH…Turning Discovery Into Health.

3

Resources - Office of Cancer Clinical Proteomics Research - National Cancer Institute

http://proteomics.cancer.gov/resources

The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. Provides samples remaining from the Mouse Proteomic Technologies Initiative. Developed from previous funding. Peer-reviewed journal articles exploring the regulatory nature of proteomics in coordination with the Food and Drug Administration,. Highlights efforts and articles that are working towards the open distribution of research data. 160; USA.gov.

4

Contact Us - Office of Cancer Clinical Proteomics Research - National Cancer Institute

http://proteomics.cancer.gov/global/contactus

The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. For more information, please contact:. Office of Cancer Clinical Proteomics Research. Center for Strategic Scientific Initiatives. Office of the Director. 31 Center Drive, MS 2580. Bethesda, MD 20892-2580. Email: cancer.proteomics@mail.nih.gov. For media inquiries, please contact:. Email: ncipressofficers@mail.nih.gov. US Department of Health and Human Services.

5

Policies - Office of Cancer Clinical Proteomics Research - National Cancer Institute

http://proteomics.cancer.gov/global/policies

The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. NIH does not endorse or recommend any commercial products, processes, or services. The views and opinions of authors expressed on NIH websites do not necessarily state or reflect those of the U.S. Government, and they may not be used for advertising or product endorsement purposes. During your visit to our Web site, your Web browser may produce pop-up advertisements&#4...

UPGRADE TO PREMIUM TO VIEW 17 MORE

TOTAL PAGES IN THIS WEBSITE

22

LINKS TO THIS WEBSITE

precisionantibody.com

A&G Pharmaceutical Awarded Phase II SBIR Grant for Development of GP88 Drug Candidate Targeted to Breast Cancer

http://precisionantibody.com/about/news/index.html

Precision Antibody Awarded SBIR Contract to Develop High-Affinity, Anti-Peptide Antibodies for SISCAPA Assays. COLUMBIA, Md., November 4, 2014. 8212;Precision Antibody, a market leader in contract antibody services, in partnership with SISCAPA Assay Technologies (SAT). Has successfully completed a Phase I SBIR contract from the National Cancer Institute (NCI). To develop high-affinity, anti-peptide antibodies for mass-spectrometry-based serum biomarker detection/quantification assays. BOSTON, Ma.,. Mayo ...

next.cancer.gov

Discovery | NExT Resources | NExT

https://next.cancer.gov/discoveryResources/cbc.htm

IP and Data Access. The NExT Diversity Library. Discovery Activities in DTP. Discovery Activities in CCR. Development Activities in DTP. Development Activities in CCR. The NExT Diversity Library. Discovery Activities in DTP. Discovery Activities in CCR. Development Activities in DTP. Development Activities in CCR. The Cancer Genome Atlas. Office of Cancer Clinical Proteomics Research. US Department of Health and Human Services. National Institutes of Health. NIH… Turning Discovery Into Health.

antibodies.cancer.gov

The Clinical Proteomic Technologies for Cancer | Partners

https://antibodies.cancer.gov/apps/site/partners

The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. Antibody Characterization Laboratory (SAIC - Frederick, NCI Frederick). Argonne National Laboratories (ANL). Developmental Studies Hybridoma Bank (DSHB) at the University of Iowa. DNASU Plasmid Repository of the Biodesign Institute at Arizona State University (DNASU). Human Protein Atlas (HPA). Ways to Partner with NCI-CPTC Antibody Characterization Program:. Material ...

antibodies.cancer.gov

The Clinical Proteomic Technologies for Cancer | About

https://antibodies.cancer.gov/apps/site/about

The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. Is to facilitate the production, characterization and distribution of these valuable reagents to the global community in order to support protein/peptide measurement and analysis efforts. US Department of Health and Human Services. National Institutes of Health.

nhlbi.ctrl.ucla.edu

NHLBI Proteomics Centers

http://nhlbi.ctrl.ucla.edu/pages/links

Last updated on: August 25, 2015. COPa Knowledgebase (COPaKB) for iPAD. The Plasma Proteome Institute. HUPO Plasma Proteome Project. NIDCR Clinical Proteomics Center at UTMB: Salivary Proteomics in Health and Disease. Clinical Proteomic Technologies for Cancer. Clinical Proteomics Program Databank by National Cancer Institute. UCLA Human Salivary Proteome Project. National Heart, Lung, And Blood Institute Clinical Proteomics Working Group report. Evolution of Clinical Proteomics and its Role in Medicine.

hkupp.org

HKUPP

http://www.hkupp.org/hupo_and_links_alllinks.htm

Kidney and Urine Protemics. European Kidney and Urine Protemics (EuroKUP). Human Proteome Organization (HUPO). Human Liver Proteome Project (HLPP) coming soon. Human Brain Proteome Project (HBPP). Proteomic Standards Initiative (PSI). Human Antibody Initiative (HAI). Plasma Proteome Project (PPP). Human Disease Glycomics/Proteome Initiative (HGPI). HUPO Cardiovascular Initiative (HUPO CVI). Mouse Models of Human Disease (MMHD) Coming Soon. Human Disease Biomarker Initiative (DBI) Coming Soon.

hkupp.kir.jp

HKUPP

http://hkupp.kir.jp/hupo_and_links_alllinks.htm

Kidney and Urine Protemics. European Kidney and Urine Protemics (EuroKUP). Human Proteome Organization (HUPO). Human Liver Proteome Project (HLPP) coming soon. Human Brain Proteome Project (HBPP). Proteomic Standards Initiative (PSI). Human Antibody Initiative (HAI). Plasma Proteome Project (PPP). Human Disease Glycomics/Proteome Initiative (HGPI). HUPO Cardiovascular Initiative (HUPO CVI). Mouse Models of Human Disease (MMHD) Coming Soon. Human Disease Biomarker Initiative (DBI) Coming Soon.

antibodies.cancer.gov

The Clinical Proteomic Technologies for Cancer | Reagent Opportunities

https://antibodies.cancer.gov/apps/site/reagent_opportunities

The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. Collaborative Opportunity for Antibody Characterization. More information about the M-CRADA can be found at the following website: http:/ ttc.nci.nih.gov/opportunities/opportunity.php? US Department of Health and Human Services. National Institutes of Health.

UPGRADE TO PREMIUM TO VIEW 44 MORE

TOTAL LINKS TO THIS WEBSITE

52

OTHER SITES

proteomics.bio.columbia.edu

Quantitative Proteomics – label-free, MSE, mass spectrometry, DIGE, 2d gel, non-isotopic

Department of Biological Sciences. Is the expressed protein complement of a cell, matrix, organelle, tissue, organ, or organism. It includes all isoforms and posttranslational variants and varies with time. The overall technical approach in proteomics was enabled by two major technical advances: the ability to fully sequence genomes and the ability to analyze proteins by mass spectrometry. Comparative and quantitative proteomics. As well as 2D gel. Based techniques to perform these comparisons. Agglomera...

proteomics.bio.ed.ac.uk

Edinburgh Proteomics Club | Edinburgh Proteomics Club

Skip to main content. Edinburgh Proteomics Club (EPC) is a platform that brings together scientists with an active or developing interest in proteomic applications and technology. Our goal is to create an open forum to exchange information and accelerate proteomics research in.

proteomics.biochemistry.iu.edu

Indiana University Proteomics

Indiana University School of Medicine. 635 Barnhill Drive, Medical Science Building 0034. Indianapolis, Indiana 46202. Indiana University School of Medicine. The IUSM Proteomics Core provides state-of-the-art proteomic tools for protein identification, quantification, and characterization on a fee-for-service basis.

proteomics.bioprojects.org

UCSD CSE - Bioinformatics

UCSD Department of Computer Science and Engineering - CSE Home. Biology has transformed into a quantitative science with the advent of technologies that produce large amounts of data, whose analyses demand advanced computation. The bioinformatics research group in CSE develops computational tools to enable biological discoveries. 9500 Gilman Drive, La Jolla, CA 92093-0114. AP&M - Our Building.

proteomics.bsd.uchicago.edu

Proteomics Core Laboratory

To get more information. The proteomics core facility is a mass spectrometry facility dedicated to the characterization of proteins and peptides. This facility provides advice and services pertaining to peptide synthesis, protein sequencing, mass spectrometry, amino acid analysis, and more.

proteomics.cancer.gov

Home - Office of Cancer Clinical Proteomics Research - National Cancer Institute

The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. Pharmacodynamic Proteomic Assay Panel for Monitoring Phospho-Signaling Networks. CPTAC researchers demonstrate utility of a pharmacodynamic multiplex immuno-MRM assay to study phosphorylated cell signaling networks. For more information, click here. CPTAC Proteomics Data Now on UCSC Genome Browser. For more information click here. Investigating RAS Signaling in Cancer.

proteomics.case.edu

Case Western Reserve University Center for Proteomics and Bioinformatics

Center for Proteomics and Bioinformatics. Modern applications of proteomics techniques followed by bioinformatics analyses put the Center for Proteomics and Bioinformatics at the forefront of translational research in the Case Western Reserve University School of Medicine. Systems Medicine Data Analysis. Instruments and Computational Facilities. Pricing and Project Submission. Download our information packet. Systems Biology and Bioinformatics Graduate Program. PRISM - Undergraduate Research Opportunities.

proteomics.cf.gu.se

Proteomics - Proteomics, Göteborgs universitet

Proteomics Core Facility håller stängt v 28-31 (4/7-2/8). Proteomics Core Facility är en teknikplattform baserad på biologisk masspektrometri (MS) vilken erbjuder vetenskaplig expertis och avancerade instrument; LTQ Orbitrap Velos, QExactive och Orbitrap Fusion Tribrid MS, för studier inom medicin och. ITRAQ/TMT) samt kvantitativ riktad proteomik. Proteomics Core Facility vid Göteborgs universitet. Box 413, 405 30 Göteborg. Medicinaregatan 7A, 413 90 Göteborg. Labb: 031 786 3482, Manager: 031-786 9790.

proteomics.cn

国家生物医学分析中心--蛋白质组学网

谈家桢生命科学奖是由国家科技部批准、联合基因集团出资设立，上海复星医药集团有限公司赞助，上海市生物医药行业协会承办的专项奖励基金。 PIAS3 induction of PRB sumoylation represses PRB transactivation by destabilizing its. Proteomics-based Identification of Human Acute Leukemia Antigens That Induce Humoral. Proteomic analysis of ubiquitin-proteasome effects: insight into the function of euka. A novel eIF5A complex functions as a regulator of p53 and p53-dependent apoptosis. CUE domain containing 2 regulates degradation of progesterone receptor by ubiquitin-p.

proteomics.co.uk

proteomics.com

Home Page | Proteome Sciences

In Safe Hands Protein and peptide biomarker solutions for pharmaceutical and diagnostics applications. Ahead of the Pack Protein and peptide biomarker solutions for pharmaceutical and diagnostics applications. Reaching new heights in biomarker solutions Protein and peptide biomarker solutions for pharmaceutical and diagnostics applications. Setting New Standards Protein and peptide biomarker solutions for pharmaceutical and diagnostics applications. Three New SysQuant Case Studies:. Our core businesses a...